Meloxicam Bluepharma

Meloxicam, the active ingredient in Meloxicam Bluepharma, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adult patients.

GNH USA supplies Meloxicam Bluepharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and improves mobility by decreasing synovial inflammation. - Rheumatoid arthritis: reduces joint swelling and pain, helping to preserve function. - Ankylosing spondylitis: diminishes spinal inflammation and associated discomfort. - Acute pain: provides rapid relief of moderate to severe pain from injuries or postoperative settings.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions including Stevens‑Johnson syndrome.

Before prescribing meloxicam, clinicians should evaluate patient risk factors and follow safety guidelines. - Assess gastrointestinal risk: review history of ulcers, bleeding or concurrent NSAID use. - Monitor cardiovascular status: consider existing heart disease or hypertension. - Evaluate renal function: check creatinine clearance in patients with kidney impairment. - Review hepatic health: avoid use in severe liver disease. - Use the lowest effective dose: limit duration to the shortest period necessary. - Store at ambient temperature: keep tablets in the original container, protect from moisture and heat.

Meloxicam can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: elevated lithium levels leading to toxicity. - Methotrexate: reduced clearance and heightened toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal perfusion and increased nephrotoxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - ACE inhibitors or ARBs: potential for reduced antihypertensive effect and renal impairment.